---

---

symbols : Nvo    source : Www.prnewswire.com   

save search

---

REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -0.78% | O: 1.1% H: 0.46% C: -2.32%
business natural million food

---

2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -1.53% | O: -0.75% H: 0.0% C: 0.0%
investments update asia

---

2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
Published: 2024-03-15 (Crawled : 09:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -7.47% | O: -0.52% H: 0.09% C: -1.13%
investments update

---

Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -6.71% | O: 1.77% H: 0.05% C: -0.93%
pharma company astrazeneca acquired agreement

---

Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -7.83% | O: -0.64% H: 0.94% C: -0.56%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -10.2% | O: 0.66% H: 0.0% C: 0.0%
LLY | $745.04 -0.12% 410K |

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABT | News | $107.145 1.78% 1.3M |

Health Technology

| -11.47% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -5.85% | O: -0.04% H: 0.0% C: 0.0%
report distribution year global market

---

Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)
Published: 2024-03-12 (Crawled : 07:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| -5.11% | O: 0.27% H: 2.67% C: 2.67%
total

---

FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Published: 2024-03-08 (Crawled : 20:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| Email alert Add to watchlist
fda obesity first treatment risk heart

---

Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.97% | O: 0.37% H: 0.58% C: 0.58%
VTRS | $11.26 1.26% 500K |

Health Technology

| -16.77% | O: 0.0% H: 1.93% C: 1.27%
NVO | $124.37 1.32% 740K |

Health Technology

| 0.01% | O: -0.68% H: 0.4% C: -0.18%
NVS | $93.43 0.93% 220K |

Health Technology

| -9.46% | O: 0.89% H: 0.4% C: 0.17%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -9.66% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -5.02% | O: 0.97% H: 0.0% C: 0.0%
report revenue global insulin growth market

---

Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in India
Published: 2024-02-06 (Crawled : 08:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 5.3% | O: 0.06% H: 0.31% C: -0.61%
hospital india

---

Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Players - Attralus, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Novo Nordisk
Published: 2024-01-24 (Crawled : 23:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 18.36% | O: 0.49% H: 0.0% C: -0.05%
IONS | $40.98 0.42% 67K |

Health Technology

| -19.35% | O: 0.38% H: 2.34% C: 1.56%
key growth market

---

Elo Life Systems Announces Oversubscribed $20.5 Million Series A2 Funding Round
Published: 2024-01-24 (Crawled : 14:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 18.18% | O: 1.21% H: 0.36% C: -1.35%
life million series funding

---

Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published: 2024-01-17 (Crawled : 22:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 16.73% | O: -0.36% H: 1.32% C: 1.18%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -9.56% | O: -0.21% H: 0.0% C: 0.0%
VRTX | News | $396.83 0.85% 190K |

Health Technology

| -8.95% | O: -0.5% H: 0.76% C: 0.32%
EDIT | $5.635 1.53% 200K |

Health Technology

| -34.01% | O: 0.83% H: 0.35% C: -3.66%
AGIO | News | $30.24 2.75% 180K |

Health Technology

| 34.27% | O: 0.41% H: 0.0% C: -2.2%
crispr companies therapeutics growth study market

---

Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -10.95% | O: 1.1% H: 0.0% C: 0.0%
NVO | $124.37 1.32% 740K |

Health Technology

| 14.59% | O: -0.33% H: 0.35% C: -1.5%
LLY | $745.04 -0.12% 410K |

Health Technology

| 19.13% | O: 0.67% H: 0.85% C: 0.21%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -12.45% | O: 0.69% H: 0.0% C: 0.0%
ALDX | News | $3.945 -0.88% 49K |

Health Technology

| 19.16% | O: -1.8% H: 0.46% C: -2.44%
companies therapeutics growth market

---

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | $138.24 -1.36% 0 |

Health Technology

| -0.26% | O: 2.71% H: 0.36% C: 0.11%
LEXX | $2.25 9.6K |

Health Technology

| 73.33% | O: 0.0% H: 8.15% C: 1.48%
PFE A | $25.44 0.2% 4.4M |

Health Technology

| -13.74% | O: -0.37% H: 1.09% C: 0.75%
NVO | $124.37 1.32% 740K |

Health Technology

| 17.5% | O: 0.19% H: 0.34% C: 0.21%
MRK | $125.29 0.05% 870K |

Health Technology

| 6.95% | O: 0.32% H: 0.26% C: -0.18%
AZN | $68.505 0.21% 580K |

Health Technology

| -0.17% | O: 0.28% H: 0.99% C: 0.93%

---

2023 Novo Holdings Seed Investments Team Annual Review/Business Update
Published: 2024-01-04 (Crawled : 08:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 20.18% | O: 1.44% H: 3.68% C: 2.4%
investments update

---

Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -3.25% | O: 3.66% H: 0.0% C: -0.12%
AZNCF | $138.24 -1.36% 0 |

Health Technology

| 3.68% | O: 3.33% H: 0.0% C: -2.93%
NVO | $124.37 1.32% 740K |

Health Technology

| 20.34% | O: -0.31% H: 0.39% C: -0.44%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -5.58% | O: 1.09% H: 0.0% C: 0.0%
LLY | $745.04 -0.12% 410K |

Health Technology

| 31.25% | O: 0.18% H: 0.5% C: -0.46%
BMY | $48.295 -0.01% 920K |

Health Technology

| -5.77% | O: -0.78% H: 5.15% C: 2.81%
ABBV | News | $165.09 0.26% 760K |

Health Technology

| 8.24% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -6.61% | O: 1.03% H: 0.0% C: 0.0%
REGN | $901.745 0.87% 87K |

Health Technology

| 7.04% | O: 0.52% H: 0.58% C: 0.05%
GILD | News | $66.52 0.54% 780K |

Health Technology

| -15.24% | O: 0.34% H: 1.02% C: 0.59%
BIIB | $190.99 0.25% 180K |

Health Technology

| -23.13% | O: 0.57% H: 1.36% C: 1.04%
AZN | $68.505 0.21% 580K |

Health Technology

| 2.96% | O: 1.06% H: 0.18% C: -1.06%
AMGN | $263.65 0.34% 360K |

Health Technology

| -5.15% | O: 0.24% H: 2.03% C: 1.49%
patent report global market

---

Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | $138.24 -1.36% 0 |

Health Technology

| 2.12% | O: -3.0% H: 2.15% C: 2.15%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -4.45% | O: 0.0% H: 0.0% C: 0.0%
NVO | $124.37 1.32% 740K |

Health Technology

| 27.07% | O: -0.48% H: 0.0% C: -0.44%
NVS | $93.43 0.93% 220K |

Health Technology

| -5.86% | O: -1.31% H: 0.56% C: -0.17%
LLY | $745.04 -0.12% 410K |

Health Technology

| 26.46% | O: -4.44% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -5.78% | O: -0.93% H: 0.0% C: 0.0%
AZN | $68.505 0.21% 580K |

Health Technology

| 2.89% | O: -2.23% H: 0.28% C: -0.11%
reach research market

---

Liberty All-Star Equity Fund November 2023 Monthly Update
Published: 2023-12-13 (Crawled : 18:00) - prnewswire.com
SNEJF | $82.28 1.1K |

Consumer Durables

| -9.27% | O: -0.26% H: 3.39% C: 3.39%
SKX 4 | $56.64 -0.39% 55K |

Consumer Non-Durables

| -8.11% | O: 1.19% H: 1.61% C: 0.58%
NOW | $718.34 -1.78% 280K |

Technology Services

| 2.91% | O: -0.79% H: 0.3% C: -4.17%
NVO | $124.37 1.32% 740K |

Health Technology

| 25.92% | O: -0.38% H: 0.21% C: -0.53%
IQV | $228.96 0.79% 53K |

Health Services

| 0.58% | O: 0.35% H: 3.61% C: 1.68%
SWKS 4 | $97.36 -0.27% 92K |

Electronic Technology

| -9.64% | O: 0.94% H: 3.45% C: 3.11%
REGN | $901.745 0.87% 87K |

Health Technology

| 2.86% | O: -0.26% H: 0.56% C: 0.25%
PYPL A | $62.085 -0.02% 2.9M |

Technology Services

| 2.48% | O: 1.96% H: 1.89% C: -1.7%
ADSK A | $214.5 1.84% 310K |

Technology Services

| -2.84% | O: 0.19% H: 3.09% C: 2.32%
AMZN | $177.79 -0.8% 9.6M |

Retail Trade

| 23.17% | O: 0.73% H: 0.41% C: -1.67%
update liberty

---

Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Published: 2023-12-11 (Crawled : 07:00) - prnewswire.com
NVO | $124.37 1.32% 740K |

Health Technology

| 28.86% | O: -0.22% H: 0.68% C: 0.23%
drug candidate series therapeutics

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 16K |

Health Technology

| -22.28% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.7 600K |

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | $9.47 520K |

Manufacturing

| -23.82% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.235 0.57% 100K |

Health Technology

| -6.61% | O: -0.64% H: 0.5% C: 0.5%
NVO | $124.37 1.32% 740K |

Health Technology

| 28.63% | O: -0.42% H: 0.67% C: 0.25%
NVS | $93.43 0.93% 220K |

Health Technology

| -2.97% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -7.07% | O: -0.18% H: 0.0% C: 0.0%
LLY | $745.04 -0.12% 410K |

Health Technology

| 27.99% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.295 -0.01% 920K |

Health Technology

| -3.71% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $165.09 0.26% 760K |

Health Technology

| 11.75% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -0.46% | O: 1.07% H: 0.0% C: 0.0%
GILD | News | $66.52 0.54% 780K |

Health Technology

| -14.29% | O: 0.08% H: 1.45% C: 1.17%
AMGN | $263.65 0.34% 360K |

Health Technology

| -2.35% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

Gainers vs Losers

82%

18%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M |

Finance

EGOX | $0.0835 131.94% 160M |

ZCMD | $2.18 50.35% 24M |

Commercial Services

CHRO | $1.73 41.22% 46K |

n/a

RWOD | $10.61 32.68% 5.1M |

n/a

NVFY | $2.77 31.28% 2.2M |

Consumer Durables

AULT | $0.3174 31.1% 28M |

Manufacturing

WISA 4 | $7.11 20.71% 4.7M |

Electronic Technology

LIFW | News | $0.99 19.26% 800K |

Administrative and Support and ...

PRTG | $0.285 18.75% 140K |

Mining, Quarrying, and Oil and ...

---

Your saved searches

---